Nanodiagnostics as a field makes use of fundamental advances in
nanobiotechnology to diagnose, characterize and manage disease at the molecular
scale. As these strategies move closer to routine clinical use, a proper
understanding of different imaging modalities, relevant biological systems and
physical properties governing nanoscale interactions is necessary to rationally
engineer next-generation bionanomaterials. In this Review, we analyse the
background physics of several clinically relevant imaging modalities and their
associated sensitivity and specificity, provide an overview of the materials
currently used for in vivo nanodiagnostics, and assess the
progress made towards clinical translation. This work provides a framework for
understanding both the impressive progress made thus far in the nanodiagnostics
field as well as presenting challenges that must be overcome to obtain
widespread clinical adoption.